Clinical Trial Update: Impact GLP-1 Agonists Following Bariatric [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the impact of GLP-1 receptor agonists after bariatric surgery. The study is currently recruiting for obesity-related/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension
• Metabolic Syndrome
• Obesity
• Obstructive Sleep Apnea

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Morbid Obesity, Metabolic Syndrome | Phase 4 | Status: RECRUITING